6 Meridian’s Gilead Sciences GILD Stock Holding History

6 Meridian’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-80,617	Closed	-$5.55M	–	435
2021 Q2	$5.55M	Sell	80,617 -2,029	-2%	-$135K	0.44%	40
2021 Q1	$5.34M	Buy	82,646 +48,228	+140%	+$3.11M	0.46%	33
2020 Q4	$2M	Sell	34,418 -419	-1%	-$25.3K	0.19%	83
2020 Q3	$2.2M	Buy	+34,837	New	+$2.42M	0.23%	74
2018 Q3	–	Sell	-101,909	Closed	-$7.22M	–	458
2018 Q2	$7.22M	Buy	101,909 +2,761	+3%	+$195K	0.77%	43
2018 Q1	$7.47M	Buy	+99,148	New	+$7.88M	0.84%	36

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

6 Meridian's GILD Position: Q3 2021 in Review

6 Meridian sold out of Gilead Sciences (GILD) in Q3 2021, closing a stake of 80,617 shares — an estimated $5.55M sold.

6 Meridian first reported a position in GILD in Q1 2018 and held it in 6 quarters. The position peaked at $7.47M in Q1 2018. 1,564 funds tracked by Wall St. Rank hold GILD as of Q3 2021.

6 Meridian reported no remaining Gilead Sciences position as of Q3 2021 after selling out during the quarter.
6 Meridian sold 80,617 Gilead Sciences shares in Q3 2021, an estimated $5.55M.
6 Meridian first reported a position in Gilead Sciences in Q1 2018 and held it in 6 quarters.
6 Meridian's Gilead Sciences position peaked at $7.47M in Q1 2018.
1,564 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2021.

Based on 6 Meridian's 13F filing for Q3 2021, filed 3 Nov 2021.